80 unknown. 80 Phase 3, 13 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 80 | Unknown 80 |
| Phase 2 | 13 | Unknown 13 |
Follow Lung Diseases, Obstructive: new trials by email Literature Review of Lung Diseases, Obstructive trials Research Report on Lung Diseases, Obstructive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Citrulline Supplementation in COPD Patients With Malnutrition L-citrulline - Chronic Obstructive Pulmonary Disease Severe, Malnutrition | Phase 3 | Unknown | University Hospital, Grenoble | 60 | 2024-01-25 | 2024-01-19 |
| Clopidogrel for the Prevention of Exacerbations in Severe COPD Clopidogrel Bisulfate 75Mg Tab - COPD, COPD Exacerbation Acute | Phase 3 | Unknown | Lady Reading Hospital, Pakistan | 162 | 2023-10-01 | 2023-10-03 |
| Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination - COPD | Phase 3 | Unknown | Neutec Ar-Ge San ve Tic A.Ş | 74 | 2023-09-28 | 2023-10-03 |
| N-acetylcysteine (NAC) for the Treatment of Acute Exacerbation of COPD N-acetylcysteine, Placebo - Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Queen Mary Hospital, Hong Kong | 80 | 2023-09-18 | 2023-11-18 |
| Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination - COPD | Phase 3 | Unknown | Neutec Ar-Ge San ve Tic A.Ş | 74 | 2023-08-25 | 2023-09-05 |
| The Addition of Inhaled Furosemide to Standard Treatment of COPD Exacerbation Furosemide, Normal saline - Chronic Obstructive Pulmonary Disease Exacerbation, COPD Exacerbation | Phase 3 | Unknown | American University of Beirut Medical Center | 200 | 2023-03-01 | 2023-03-15 |
| Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals, ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK, Placebo - Asthma | Phase 3 | Unknown | Respirent Pharmaceuticals Co Ltd. | 451 | 2023-01-30 | 2023-03-01 |
| Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma Flamboyant 125/12, Budesonide/formoterol 200/6, Flamboyant 125/12 Placebo - Asthma | Phase 3 | Unknown | EMS | 134 | 2022-07-22 | 2022-07-27 |
| Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma Flamboyant 200/12, Budesonide / Formoterol 400/12, Flamboyant 200/12 Placebo - Asthma | Phase 3 | Unknown | EMS | 134 | 2022-07-22 | 2022-07-27 |
| To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma Fluticasone propionate Inhalation Aerosol 44 mcg, FLOVENT HFA 44 mcg, Matching Placebo inhaler - Bronchial Asthma | Phase 3 | Unknown | Glenmark Pharmaceuticals Ltd. India | 790 | 2022-04-15 | 2022-05-27 |
| Inhaled Amikacin in Preventing AECOPD aerosol inhaled Amikacin Sulfate Injection, conventional therapy - COPD, COPD Exacerbation | Phase 3 | Unknown | Shanghai Zhongshan Hospital | 136 | 2022-03-01 | 2022-02-23 |
| The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.) Conventional rehabilition treatment(e.g leaflet) educated by hospital, Digital treatment based on Respiratory Rehabilitation Software - Respiratory System Disease, Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Lifesemantics Corp. | 100 | 2022-01-13 | 2022-03-29 |
| Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD Acetazolamide, Placebo - Chronic Obstructive Pulmonary Disease, Altitude Sickness | Phase 3 | Unknown | University of Zurich | 100 | 2021-06-01 | 2023-03-03 |
| Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude Acetazolamide, Placebo - Right Heart Function, Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | University of Zurich | 100 | 2021-05-01 | 2022-11-02 |
| A Trial of Procalcitonin in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease procalcitonin-guided antibiotic therapy, guideline-guided antibiotic therapy - Procalcitonin, Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Capital Medical University | 500 | 2021-02-01 | 2020-12-24 |
| Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics Magnesium Sulfate, Placebo - Asthma in Children | Phase 2 / Phase 3 | Unknown | Oman Medical Speciality Board | 90 | 2020-08-01 | 2020-07-13 |
| Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure Yiqi Huoxue Huatan granule, Placebo Yiqi Huoxue Huatan granule - Chronic Obstructive Pulmonary Disease, Chronic Respiratory Failure | Phase 3 | Unknown | Peking University People's Hospital | 372 | 2019-10-08 | 2020-01-07 |
| High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients. 4-Aminopyridine, Placebo oral capsule - Spinal Cord Injuries, Chronic | Phase 3 | Unknown | Coordinación de Investigación en Salud, Mexico | 150 | 2019-07-17 | 2021-02-21 |
| Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD Bufei Yishen granule, Placebo Bufei Yishen granule, Tiotropium Bromide Powder for Inhalation - Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 348 | 2019-06-01 | 2019-06-06 |
| Bufei Jianpi Granule for Delaying Pulmonary Function Decline in Early-Stage COPD Bufei Jianpi granule, Placebo Bufei Jianpi granule - Chronic Obstructive Pulmonary Disease | Phase 3 | Unknown | Henan University of Traditional Chinese Medicine | 612 | 2019-06-01 | 2019-06-06 |
Showing 20 of 80. Sign in to see all of them.
Pulmonary Disease, Chronic Obstructive (41) · Asthma (27) · Bronchiolitis Obliterans Syndrome (7) · Bronchitis (5) · Emphysema (4) · Dyspnea (3) · Heart Failure (3) · Lymphoma, Follicular (3) · Altitude Sickness (2) · Cough (2) · Hypertension, Pulmonary (2) · Inflammation (2) · Lung Neoplasms (2) · Respiratory Tract Diseases (2) · Sleep Apnea, Obstructive (2)
Lung Diseases (79) · Respiratory Tract Diseases (78) · Pathological Conditions, Signs and Symptoms (47) · Pathologic Processes (44) · Chronic Disease (41) · Disease Attributes (41) · Bronchial Diseases (40) · Immune System Diseases (35) · Hypersensitivity, Immediate (27) · Respiratory Hypersensitivity (27) · Hypersensitivity (26) · Respiration Disorders (9) · Bronchitis (8) · Signs and Symptoms (8)
Fluticasone-Salmeterol Drug Combination (8) · Albuterol (7) · Salmeterol Xinafoate (7) · Budesonide (6) · Fluticasone (5) · montelukast (4) · Azithromycin (3) · Inhalation (3) · Acetazolamide (2) · Formoterol Fumarate (2) · Ipratropium (2) · Saline Solution (2) · Standard of Care (2) · Tiotropium Bromide (2) · 4-Aminopyridine (1)
Henan University of Traditional Chinese Medicine (8) · Amneal Ireland Limited (2) · Assistance Publique - Hôpitaux de Paris (2) · EMS (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Neutec Ar-Ge San ve Tic A.Ş (2) · University of Zurich (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ajou University School of Medicine (1) · American University of Beirut Medical Center (1) · Associazione Riabilitatori Insufficienza Respiratoria (1) · Bridgeport Hospital (1) · Broncus Technologies (1) · C. T. Lamont Primary Care Research Centre (1) · CHU de Reims (1)
China (12) · United Kingdom (8) · United States (8) · France (5) · Brazil (4) · Germany (4) · Netherlands (4) · South Korea (4) · Spain (4) · Canada (3) · Italy (3) · India (2) · Kyrgyzstan (2) · Mexico (2) · Poland (2)
Irshad Haque (2) · Jiansheng Li, Professor (2) · Suyun Li, Doctor (2) · Alok Nath, MD (1) · Ameet Daftary (1) · Andreas M Zeiher, MD (1) · Andrew Wilson, MD, MRCP (UK) (1) · Aubier Michel (1) · Birgit Assmus, MD (1) · Carmine D. Vizza, MD (1) · Christopher Corrigan, MD, PhD (1) · Chunhua Zhao, MD,PHD (1) · Constantine Manthous, MD (1)
PMID 36472162, PMID 17356056, PMID 18385168, PMID 18595980, PMID 18710905, PMID 18723437, PMID 19535666, PMID 19726699, PMID 19797480, PMID 19817753, PMID 20008582, PMID 20090057, PMID 20154234, PMID 20420722, PMID 20525652, PMID 20526242, PMID 20538327, PMID 20620566, PMID 20870246, PMID 21214899, PMID 21315433, PMID 21599896, PMID 21771118, PMID 21861914, PMID 21907863, PMID 21986034, PMID 22093109, PMID 22330698, PMID 22459779, PMID 22532985, PMID 22893340, PMID 23506695, PMID 23595876, PMID 23792089, PMID 24067388, PMID 24447429, PMID 24506910, PMID 24650447, PMID 24698320, PMID 24838406, PMID 24885672, PMID 24989842, PMID 25277142, PMID 25358424, PMID 25631639, PMID 25640020, PMID 25643669, PMID 25724847, PMID 25732539, PMID 25749414
2009 (1)